GOLDMAN SACHS GROUP INC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 40 filers reported holding ACORDA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$5,928,000
+77.3%
6,080,0000.0%0.00%0.0%
Q4 2020$3,344,000
-35.8%
6,080,0000.0%0.00%0.0%
Q3 2020$5,208,000
-1.0%
6,080,0000.0%0.00%
-50.0%
Q2 2020$5,261,000
-0.7%
6,080,0000.0%0.00%0.0%
Q1 2020$5,296,000
+15.9%
6,080,0000.0%0.00%
+100.0%
Q4 2019$4,570,000
-3.9%
6,080,0000.0%0.00%0.0%
Q3 2019$4,757,000
-6.8%
6,080,000
+1.3%
0.00%0.0%
Q2 2019$5,104,000
+163.8%
6,000,000
+199.7%
0.00%0.0%
Q2 2018$1,935,000
+23.8%
2,002,000
-2.7%
0.00%
Q4 2016$1,563,000
-17.0%
2,057,000
-10.8%
0.00%
-100.0%
Q3 2016$1,882,000
+10970.6%
2,307,000
+12042.1%
0.00%
Q1 2016$17,000
-99.7%
19,000
-99.6%
0.00%
-100.0%
Q4 2014$4,927,000
-13.6%
4,282,000
-22.1%
0.00%0.0%
Q3 2014$5,701,0005,495,0000.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 8,750,000$6,650,0003.76%
Mohican Financial Management, LLC 3,000,000$2,280,0002.84%
BASSO CAPITAL MANAGEMENT, L.P. 11,200,000$8,512,0001.28%
ANGELO GORDON & CO., L.P. 22,500,000$17,100,0001.26%
Context Capital Management, LLC 1,500,000$1,140,0001.25%
Opera Trading Capital 4,500,000$3,400,0001.02%
Jabre Capital Partners S.A. 6,650,000$5,037,0000.58%
Castle Creek Arbitrage, LLC 6,000,000$4,576,0000.44%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 28,000,000$21,345,000,0000.41%
Man Investments (CH) AG 700,000$536,0000.31%
View complete list of ACORDA THERAPEUTICS INC shareholders